The World Health Organisation’s (WHO) chief scientist Soumya Swaminathan said this week that Sputnik V is likely to get Emergency Use Listing (EUL) status by the end of this year. So far, Pfizer-BioNTech, Moderna, Janssen, Sinopharm, Sinovac, and AstraZeneca (both variants) have been given the emergency us status by WHO.